Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction.

Del Puerto-Nevado L, Santiago-Hernandez A, Solanes-Casado S, Gonzalez N, Ricote M, Corton M, Prieto I, Mas S, Sanz AB, Aguilera O, Gomez-Guerrero C, Ayuso C, Ortiz A, Rojo F, Egido J, Garcia-Foncillas J, Minguez P, Alvarez-Llamas G; DiabetesCancerConnect Consortium.

Mol Oncol. 2019 Sep;13(9):1887-1897. doi: 10.1002/1878-0261.12531. Epub 2019 Jul 27.

2.

Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions.

McNicholl AG, Amador J, Ricote M, Cañones-Garzón PJ, Gene E, Calvet X, Gisbert JP; Spanish Primary Care Societies SEMFyC; SEMERGEN and SEMG, the Spanish Association of Gastroenterology; OPTICARE Long-Term Educational Project.

Helicobacter. 2019 Aug;24(4):e12593. doi: 10.1111/hel.12593. Epub 2019 May 20.

PMID:
31111627
3.

Isolation and Purification of Tissue Resident Macrophages for the Analysis of Nuclear Receptor Activity.

Alonso-Herranz L, Porcuna J, Ricote M.

Methods Mol Biol. 2019;1951:59-73. doi: 10.1007/978-1-4939-9130-3_5.

PMID:
30825144
4.

Flow Cytometry Has a Significant Impact on the Cellular Metabolome.

Binek A, Rojo D, Godzien J, Rupérez FJ, Nuñez V, Jorge I, Ricote M, Vázquez J, Barbas C.

J Proteome Res. 2019 Jan 4;18(1):169-181. doi: 10.1021/acs.jproteome.8b00472. Epub 2018 Nov 2.

PMID:
30362351
5.

C-reactive protein expression in adipose tissue of children with acute appendicitis.

de Dios O, Gavela-Pérez T, Aguado-Roncero P, Pérez-Tejerizo G, Ricote M, González N, Garcés C, Soriano-Guillén L.

Pediatr Res. 2018 Oct;84(4):564-567. doi: 10.1038/s41390-018-0091-z. Epub 2018 Jul 10.

PMID:
29991774
6.

Deciphering the Dynamic Transcriptional and Post-transcriptional Networks of Macrophages in the Healthy Heart and after Myocardial Injury.

Walter W, Alonso-Herranz L, Trappetti V, Crespo I, Ibberson M, Cedenilla M, Karaszewska A, Núñez V, Xenarios I, Arroyo AG, Sánchez-Cabo F, Ricote M.

Cell Rep. 2018 Apr 10;23(2):622-636. doi: 10.1016/j.celrep.2018.03.029.

7.

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.

Clemente C, Rius C, Alonso-Herranz L, Martín-Alonso M, Pollán Á, Camafeita E, Martínez F, Mota RA, Núñez V, Rodríguez C, Seiki M, Martínez-González J, Andrés V, Ricote M, Arroyo AG.

Nat Commun. 2018 Mar 2;9(1):910. doi: 10.1038/s41467-018-03351-4.

8.

Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages.

Moore-Morris T, Cattaneo P, Guimarães-Camboa N, Bogomolovas J, Cedenilla M, Banerjee I, Ricote M, Kisseleva T, Zhang L, Gu Y, Dalton ND, Peterson KL, Chen J, Pucéat M, Evans SM.

Circ Res. 2018 Feb 16;122(4):583-590. doi: 10.1161/CIRCRESAHA.117.311490. Epub 2017 Dec 21.

9.

Endogenous retinoid X receptor ligands in mouse hematopoietic cells.

Niu H, Fujiwara H, di Martino O, Hadwiger G, Frederick TE, Menéndez-Gutiérrez MP, Ricote M, Bowman GR, Welch JS.

Sci Signal. 2017 Oct 31;10(503). pii: eaan1011. doi: 10.1126/scisignal.aan1011.

10.

Phagocytosis imprints heterogeneity in tissue-resident macrophages.

A-Gonzalez N, Quintana JA, García-Silva S, Mazariegos M, González de la Aleja A, Nicolás-Ávila JA, Walter W, Adrover JM, Crainiciuc G, Kuchroo VK, Rothlin CV, Peinado H, Castrillo A, Ricote M, Hidalgo A.

J Exp Med. 2017 May 1;214(5):1281-1296. doi: 10.1084/jem.20161375. Epub 2017 Apr 21.

11.

The multi-faceted role of retinoid X receptor in bone remodeling.

Menéndez-Gutiérrez MP, Ricote M.

Cell Mol Life Sci. 2017 Jun;74(12):2135-2149. doi: 10.1007/s00018-017-2458-4. Epub 2017 Jan 19. Review.

PMID:
28105491
12.

Peroxisome proliferator activated receptor gamma 2 modulates late pregnancy homeostatic metabolic adaptations.

Vivas Y, Díez-Hochleitner M, Izquierdo-Lahuerta A, Corrales P, Horrillo D, Velasco I, Martínez-García C, Campbell M, Sevillano J, Ricote M, Ros M, Ramos MP, Medina-Gomez G.

Mol Med. 2016 Dec;22:724-736. doi: 10.2119/molmed.2015.00262. Epub 2016 Oct 19.

13.

Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.

Natrajan MS, de la Fuente AG, Crawford AH, Linehan E, Nuñez V, Johnson KR, Wu T, Fitzgerald DC, Ricote M, Bielekova B, Franklin RJ.

Brain. 2015 Dec;138(Pt 12):3581-97. doi: 10.1093/brain/awv289. Epub 2015 Oct 12.

14.

GOplot: an R package for visually combining expression data with functional analysis.

Walter W, Sánchez-Cabo F, Ricote M.

Bioinformatics. 2015 Sep 1;31(17):2912-4. doi: 10.1093/bioinformatics/btv300. Epub 2015 May 11.

PMID:
25964631
15.

Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.

Menéndez-Gutiérrez MP, Rőszer T, Fuentes L, Núñez V, Escolano A, Redondo JM, De Clerck N, Metzger D, Valledor AF, Ricote M.

J Clin Invest. 2015 Feb;125(2):809-23. doi: 10.1172/JCI77186. Epub 2015 Jan 9.

16.

Retinoid X receptor α attenuates host antiviral response by suppressing type I interferon.

Ma F, Liu SY, Razani B, Arora N, Li B, Kagechika H, Tontonoz P, Núñez V, Ricote M, Cheng G.

Nat Commun. 2014 Nov 24;5:5494. doi: 10.1038/ncomms6494.

17.

Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.

Ballesteros I, Cuartero MI, Pradillo JM, de la Parra J, Pérez-Ruiz A, Corbí A, Ricote M, Hamilton JA, Sobrado M, Vivancos J, Nombela F, Lizasoain I, Moro MA.

J Leukoc Biol. 2014 Apr;95(4):587-98. doi: 10.1189/jlb.0613326. Epub 2013 Dec 12.

PMID:
24338629
18.

Retinoid X receptors in macrophage biology.

Rőszer T, Menéndez-Gutiérrez MP, Cedenilla M, Ricote M.

Trends Endocrinol Metab. 2013 Sep;24(9):460-8. doi: 10.1016/j.tem.2013.04.004. Epub 2013 May 20. Review.

PMID:
23701753
19.

Biology and therapeutic applications of peroxisome proliferator- activated receptors.

Menendez-Gutierrez MP, Roszer T, Ricote M.

Curr Top Med Chem. 2012;12(6):548-84. Review.

PMID:
22242855
20.

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.

Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Orešič M, Ricote M, Vidal-Puig A.

Diabetes. 2011 Mar;60(3):797-809. doi: 10.2337/db10-0705. Epub 2011 Jan 24.

21.

Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency.

Roszer T, Menéndez-Gutiérrez MP, Lefterova MI, Alameda D, Núñez V, Lazar MA, Fischer T, Ricote M.

J Immunol. 2011 Jan 1;186(1):621-31. doi: 10.4049/jimmunol.1002230. Epub 2010 Dec 6.

22.

PPARs in the Renal Regulation of Systemic Blood Pressure.

Roszer T, Ricote M.

PPAR Res. 2010;2010:698730. doi: 10.1155/2010/698730. Epub 2010 Jun 8.

23.

Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.

Fuentes L, Roszer T, Ricote M.

Mediators Inflamm. 2010;2010:219583. doi: 10.1155/2010/219583. Epub 2010 May 20. Review.

24.

Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression.

Núñez V, Alameda D, Rico D, Mota R, Gonzalo P, Cedenilla M, Fischer T, Boscá L, Glass CK, Arroyo AG, Ricote M.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10626-31. doi: 10.1073/pnas.0913545107. Epub 2010 May 24.

25.

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.

Prieur X, Roszer T, Ricote M.

Biochim Biophys Acta. 2010 Mar;1801(3):327-37. doi: 10.1016/j.bbalip.2009.09.017. Epub 2009 Sep 29. Review.

PMID:
19796705
26.

Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer.

Bouraoui Y, Ricote M, García-Tuñón I, Rodriguez-Berriguete G, Touffehi M, Rais NB, Fraile B, Paniagua R, Oueslati R, Royuela M.

Cancer Detect Prev. 2008;32(1):23-32. doi: 10.1016/j.cdp.2008.02.007. Epub 2008 Apr 9.

PMID:
18400418
27.

OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).

García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.

Cancer Invest. 2008 Apr-May;26(3):222-9. doi: 10.1080/07357900701638491.

PMID:
18317962
28.

Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes.

Pascual G, Ricote M, Hevener AL.

Expert Opin Ther Targets. 2007 Nov;11(11):1503-20. Review.

PMID:
18028013
29.

Influence of IFN-gamma and its receptors in human breast cancer.

García-Tuñón I, Ricote M, Ruiz A A, Fraile B, Paniagua R, Royuela M.

BMC Cancer. 2007 Aug 14;7:158.

30.

Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.

Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M.

J Clin Invest. 2007 Jun;117(6):1658-69. Epub 2007 May 24.

31.

PPARs and molecular mechanisms of transrepression.

Ricote M, Glass CK.

Biochim Biophys Acta. 2007 Aug;1771(8):926-35. Epub 2007 Mar 12. Review.

32.

P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.

Ricote M, García-Tuñón I, Fraile B, Fernández C, Aller P, Paniagua R, Royuela M.

Apoptosis. 2006 Nov;11(11):1969-75.

PMID:
17031491
33.

Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative).

García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.

Cancer Sci. 2006 Oct;97(10):1044-9.

34.

Normal hematopoiesis after conditional targeting of RXRalpha in murine hematopoietic stem/progenitor cells.

Ricote M, Snyder CS, Leung HY, Chen J, Chien KR, Glass CK.

J Leukoc Biol. 2006 Oct;80(4):850-61. Epub 2006 Aug 3.

PMID:
16888087
36.

The p38 transduction pathway in prostatic neoplasia.

Ricote M, García-Tuñón I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R, Royuela M.

J Pathol. 2006 Feb;208(3):401-7.

PMID:
16369914
37.

IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma.

Garcia-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.

Histopathology. 2005 Jul;47(1):82-9.

PMID:
15982327
38.

Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma.

Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, Ricote M.

J Immunol. 2004 Jun 15;172(12):7530-6.

39.

Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.

Ricote M, García-Tuñón I, Bethencourt FR, Fraile B, Paniagua R, Royuela M.

Cancer. 2004 Apr 1;100(7):1388-96.

40.

Nuclear receptor signaling in macrophages.

Valledor AF, Ricote M.

Biochem Pharmacol. 2004 Jan 15;67(2):201-12. Review.

PMID:
14698033
41.

Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.

Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.

J Pathol. 2004 Jan;202(1):41-9.

PMID:
14694520
42.

Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study.

García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M.

Breast Cancer Res. 2004;6(1):R1-7. Epub 2003 Oct 22.

43.

Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.

Ricote M, Valledor AF, Glass CK.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):230-9. Epub 2003 Oct 30. Review.

PMID:
14592855
44.

Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma.

Ricote M, Royuela M, García-Tuñón I, Bethencourt FR, Paniagua R, Fraile B.

J Urol. 2003 Sep;170(3):787-90.

PMID:
12913698
45.

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK.

Proc Natl Acad Sci U S A. 2003 May 27;100(11):6712-7. Epub 2003 May 9.

46.

WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.

Cunard R, DiCampli D, Archer DC, Stevenson JL, Ricote M, Glass CK, Kelly CJ.

J Immunol. 2002 Dec 15;169(12):6806-12.

47.

Control of the annual testicular cycle of the marbled-newt by p53, p21, and Rb gene products.

Ricote M, Alfaro JM, García-Tuñón I, Arenas MI, Fraile B, Paniagua R, Royuela M.

Mol Reprod Dev. 2002 Oct;63(2):202-9.

PMID:
12203830
48.

Immunohistochemical detection of the retinoid acid receptors (RXR-alpha, -beta, -gamma) and Farnesoid X-activated receptor (FXR) in the marbled newt along the annual cycle.

Alfaro JM, Ricote M, Lobo MV, Royuela M, Fraile B, Paniagua R, Arenas MI.

Mol Reprod Dev. 2002 Jun;62(2):216-22.

PMID:
11984832
49.

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee YH, Ricote M, Glass CK, Brewer HB Jr, Gonzalez FJ.

Mol Cell Biol. 2002 Apr;22(8):2607-19.

50.

Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors.

Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, Kelly CJ.

J Immunol. 2002 Mar 15;168(6):2795-802.

Supplemental Content

Loading ...
Support Center